Project Grant HT94252410359
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
This federal Project Grant award of $293,978.00 was issued by the Defense Health Agency on November 1, 2024 to the University of Illinois under the Military Medical Research and Development (CFDA 12.420) program. The grant is designed to support advanced biomedical research focused on cognition, vascular function, and physical activity in multiple sclerosis. The research, to be conducted over a 2-year period ending on October 31, 2026, aims to transform healthcare for military service members...
The U.S. Department of the Army Medical Command awarded a $357,989 Project Grant to the University of Cincinnati under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports the development of "Magnetophotothermal Nanoparticle Drug Delivery for Treating Noise-Induced Hearing Loss" over a 2-year period from September 1, 2025 to August 31, 2027. The project aims to advance innovative approaches to the prevention, diagnosis, and...
The Department of the Army Medical Command awarded a $1,170,000.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to the Regents of the University of Michigan. The grant, awarded on May 15, 2025, will fund a research project titled "Systemically Administered Bispecific Antibodies that Activate Neurotrophin Receptors for Treating Noise-Induced Inner Ear Damage". The project aims to develop innovative bispecific antibody therapies...
This $284,659 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will fund research at the University of Illinois to investigate the "Regeneration of the Bone Marrow Hematopoietic Niche by Jagged1-Expressing Myeloid-Derived Suppressor Cells." The research, spanning from December 1, 2024 to November 30, 2026, aims to explore innovative approaches to disease prevention, diagnosis, treatment, and...
The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
The Department of the Army Medical Command awarded a $1,475,000 project grant to Southern Illinois University School of Medicine to develop new therapies that stimulate hair cell regeneration. The grant was awarded on August 1, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will support the research efforts through July 31, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
The University of Illinois received a $1,599,997.00 Project Grant award from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct multiple sclerosis clinical trials. The award period runs from September 1, 2024, to August 31, 2027. The Military Medical Research and Development program supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. This grant award will fund the...